US Capitol Capsule: Ethics of drug trials in dire situations debated
This article was originally published in Scrip
Executive Summary
The waning Ebola epidemic in West Africa, in which more than 25,500 people have been infected with the virus, which has killed about 10,600, is likely to be over long before the debate is settled about whether using randomized controlled trials (RCTs) is ethical to test drugs and vaccines in dire situations when a deadly infectious disease is rapidly spreading.